WO2007143959A3 - Tablet containing metformin - Google Patents
Tablet containing metformin Download PDFInfo
- Publication number
- WO2007143959A3 WO2007143959A3 PCT/CZ2007/000056 CZ2007000056W WO2007143959A3 WO 2007143959 A3 WO2007143959 A3 WO 2007143959A3 CZ 2007000056 W CZ2007000056 W CZ 2007000056W WO 2007143959 A3 WO2007143959 A3 WO 2007143959A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tablet containing
- containing metformin
- percent
- weight
- active substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Abstract
Tablet containing metformin or pharmacologically acceptable salts thereof, where the active substance release is controlled by a hydrophobic polymer; the tablet contains 60 to 80 percent by weight of the active substance and 9 to 25 percent by weight of the hydrophobic polymer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ20060392A CZ300698B6 (en) | 2006-06-16 | 2006-06-16 | Metformin-containing tablet |
CZPV2006-392 | 2006-06-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007143959A2 WO2007143959A2 (en) | 2007-12-21 |
WO2007143959A3 true WO2007143959A3 (en) | 2008-02-14 |
Family
ID=38721769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CZ2007/000056 WO2007143959A2 (en) | 2006-06-16 | 2007-06-18 | Tablet containing metformin |
Country Status (2)
Country | Link |
---|---|
CZ (1) | CZ300698B6 (en) |
WO (1) | WO2007143959A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8323692B2 (en) * | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
WO2007063946A1 (en) | 2005-11-30 | 2007-06-07 | Fujifilm Ri Pharma Co., Ltd. | Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033448A1 (en) * | 1997-12-23 | 1999-07-08 | Merck Patent Gmbh | Tablet for instant and prolonged release of one or more active substances |
WO2003004009A1 (en) * | 2001-07-02 | 2003-01-16 | Geneva Pharmaceuticals, Inc. | Pharmaceutical composition |
WO2003072089A1 (en) * | 2002-02-21 | 2003-09-04 | Biovail Laboratories Inc. | Controlled release dosage forms |
WO2004012699A2 (en) * | 2002-08-05 | 2004-02-12 | Torrent Pharmaceuticals Limited | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent |
WO2005037255A1 (en) * | 2003-10-16 | 2005-04-28 | Novartis Ag | Tablet with aqueous based-sustained release coating |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ506202A (en) * | 1998-03-19 | 2003-10-31 | Bristol Myers Squibb Co | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
-
2006
- 2006-06-16 CZ CZ20060392A patent/CZ300698B6/en not_active IP Right Cessation
-
2007
- 2007-06-18 WO PCT/CZ2007/000056 patent/WO2007143959A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033448A1 (en) * | 1997-12-23 | 1999-07-08 | Merck Patent Gmbh | Tablet for instant and prolonged release of one or more active substances |
WO2003004009A1 (en) * | 2001-07-02 | 2003-01-16 | Geneva Pharmaceuticals, Inc. | Pharmaceutical composition |
WO2003072089A1 (en) * | 2002-02-21 | 2003-09-04 | Biovail Laboratories Inc. | Controlled release dosage forms |
WO2004012699A2 (en) * | 2002-08-05 | 2004-02-12 | Torrent Pharmaceuticals Limited | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent |
WO2005037255A1 (en) * | 2003-10-16 | 2005-04-28 | Novartis Ag | Tablet with aqueous based-sustained release coating |
Also Published As
Publication number | Publication date |
---|---|
CZ2006392A3 (en) | 2007-12-27 |
WO2007143959A2 (en) | 2007-12-21 |
CZ300698B6 (en) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2661102C (en) | Thiophene derivatives as s1p1/edg1 receptor agonists | |
WO2009057079A3 (en) | Novel pyrimidine derivatives | |
WO2009113703A3 (en) | Orally-disintegrating solid preparation | |
WO2008108491A1 (en) | Pest control composition | |
MX2010005889A (en) | Novel thiophene derivatives. | |
PL1906939T3 (en) | Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values | |
WO2009016460A3 (en) | Pyrazole compounds and their use as raf inhibitors | |
WO2007084728A3 (en) | 2-imino-benzimidazoles | |
WO2007003962A3 (en) | Gpcr agonists | |
WO2007003961A3 (en) | Gpcr agonists | |
EP1889842A4 (en) | Heterocyclic compound | |
TW200744588A (en) | Pharmaceutical composition for external use | |
WO2008090555A3 (en) | Medical devices having a matrix adhered thereof | |
WO2011012816A3 (en) | Pharmaceutical formulation | |
WO2009059701A3 (en) | Sustained release tablets with hydromorphone | |
WO2006127379A3 (en) | Par2-modulating compounds and their use | |
WO2008123395A1 (en) | Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient | |
WO2009060952A1 (en) | Novel preparation | |
WO2011077239A3 (en) | Slow release pharmaceutical compositions of iloperidone | |
EP2241310A3 (en) | Modified release formulations of emoxypine | |
WO2009072334A1 (en) | Core particle for pharmaceutical preparation | |
WO2009038412A3 (en) | Beta-secretase inhibiting compounds | |
SI1994926T1 (en) | Valsartan formulations | |
WO2007143959A3 (en) | Tablet containing metformin | |
WO2009069355A1 (en) | Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07721845 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07721845 Country of ref document: EP Kind code of ref document: A2 |